27-Feb-2026
Real estate stocks outperform broader markets for second straight month
Seeking Alpha News (Sat, 28-Feb 12:00 PM ET)
Business Wire (Fri, 27-Feb 5:30 PM ET)
Healthpeak CEO to Present at Citi Property Conference
TipRanks (Fri, 27-Feb 8:36 AM ET)
Healthpeak Properties's Janus Living files preliminary prospectus for IPO
Seeking Alpha News (Fri, 27-Feb 8:31 AM ET)
Healthpeak's Strategic Moves Signal Focus on Senior Housing and Life Science Real Estate
Market Chameleon (Tue, 3-Feb 3:52 AM ET)
Healthpeak Properties Provides Strategic Initiatives Update and Reports Fourth Quarter 2025 Results
Business Wire (Mon, 2-Feb 4:15 PM ET)
Healthpeak Advances AI-Enabled Operating Platform, Naming Omkar Joshi Head of Enterprise Innovation
Business Wire (Wed, 21-Jan 4:15 PM ET)
Healthpeak Properties Announces Tax Treatment of 2025 Distributions
Business Wire (Thu, 15-Jan 4:15 PM ET)
Healthpeak Properties Announces $925 Million of Transaction Activity
Business Wire (Mon, 12-Jan 6:59 AM ET)
Business Wire (Fri, 9-Jan 4:15 PM ET)
Healthpeak owns a diversified healthcare portfolio of approximately 700 in-place properties spread across mainly medical office and life science assets, plus a handful of senior housing, hospital, and skilled nursing/post-acute care assets, as well.
Healthpeak Properties trades on the NYSE stock market under the symbol DOC.
As of February 27, 2026, DOC stock price climbed to $17.68 with 12,097,996 million shares trading.
DOC has a beta of 0.40, meaning it tends to be less sensitive to market movements. DOC has a correlation of 0.08 to the broad based SPY ETF.
DOC has a market cap of $12.29 billion. This is considered a Large Cap stock.
Last quarter Healthpeak Properties reported $719 million in Revenue and $.47 earnings per share. This beat revenue expectation by $26 million and exceeded earnings estimates by $.25.
In the last 3 years, DOC traded as high as $23.26 and as low as $10.52.
The top ETF exchange traded funds that DOC belongs to (by Net Assets): VNQ, VTI, VOO, VB, RSP.
DOC has underperformed the market in the last year with a return of -6.8%, while the SPY ETF gained +18.5%. In the last 3 month period, DOC fell short of the market, returning -1.3%, while SPY returned +1.2%. However, in the most recent 2 weeks DOC has outperformed the stock market by returning +5.9%, while SPY returned +0.6%.
DOC support price is $17.20 and resistance is $17.82 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DOC shares will trade within this expected range on the day.